Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD
Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene
Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co
New data suggest there may be twice as many people with HD symptoms as previously thought – and even more at risk
Merger of two major Huntington’s Disease observational trials creates ENROLL-HD
Two clinical trials in Europe and the USA have suggested a new drug, Huntexil, might improve movements in HD. The nex
DOMINO clinical trial result: minocycline doesn’t slow down HD and shouldn’t be studied in larger trials.
The one-year report from the TRACK-HD study demonstrates a number of changes in pre-symptomatic HD-mutation carriers